Android app on Google Play

Valeant Pharmaceuticals (VRX) Announces $1.5B Securites Repurchase Program

November 19, 2012 8:07 AM EST Send to a Friend
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced an $1.5 billion securities repurchase program.

Under the Securities Repurchase Program, which commenced November 15, 2012, the Company may make purchases of up to $1.5 billion of its senior notes, common shares and/or other debt or shares that may be issued prior to the completion of the program. The Securities Repurchase Program will replace the Company's former securities repurchase program, which expired on November 7, 2012.




You May Also Be Interested In


Related Categories

Stock Buybacks

Add Your Comment